DexCom, Inc. vs Western Digital Corp — how do they compare? DexCom, Inc. trades at $76.86 (market cap $28.06B), while Western Digital Corp trades at $466.46 (market cap $177.11B). The key difference: Western Digital Corp is far larger — about 6.3× DexCom, Inc.'s market cap, and Western Digital Corp pays a 0.12% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WDC | |
|---|---|---|
Market Cap | $28.06B | $177.11B |
Sector | Health | Technology |
52-Week High | $89.53 | $746.23 |
52-Week Low | $54.84 | $66.53 |
Enterprise Value | $27.03B | $175.46B |
Dividend Yield | — | 0.12% |
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
WDC is trading at $463.5, down 17.72% amid a sector-wide sell-off in memory stocks. Despite strong fundamentals with net income margin of 55.07% and three consecutive quarterly EPS beats, technical indicators show bearish momentum with key support at $448. Recent news highlights volatility from competitor IPOs and AI-driven demand fluctuations, while analyst consensus remains strongly bullish with a $619.07 price target.
The outlook balances robust profitability against near-term sector headwinds. Investment opportunity lies in AI storage demand and margin expansion, but risks include intense competition and cyclical memory pricing. Wall Street's 72% buy rating reflects confidence in long-term growth despite current technical weakness.
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →